COMP <GO>
AGX vs LGN // EV/EBITDA & P/E VALUATION
Argan Inc. (NYSE) VS. Legence Corp. (Class A) (NASDAQ) • 15-METRIC TALLY: AGX 10
— LGN 2
▲ EV/EBITDA & P/E VALUATION LEADER: AGX
LAST: $356.85 (+1.18%) • MKT CAP: $5.01B
valuation
36.0x
LAST: $41.90 (+2.67%) • MKT CAP: $4.53B
valuation
45.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AGX VS. LGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AGX | LGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.50% | 21.00% | -0.50 | LGN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 24.90% | 21.50% | +3.40 | AGX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 36.0x | 45.8x | -9.80 | AGX | /valuation <GO> |
| Free Cash Flow Yield | 8.21% | 4.83% | +3.38 | AGX | /fcf-yield <GO> |
| Operating Margin | 14.30% | 2.40% | +11.90 | AGX | /operating-margins <GO> |
| Net Profit Margin | 14.60% | -2.30% | +16.90 | AGX | /net-margins <GO> |
| Revenue Growth (YoY) | 8.10% | 21.50% | -13.40 | LGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.48% | 0.00% | +0.48 | AGX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.22 | 2.48 | +3.74 | AGX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | AGX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.8 | 35.1 | +10.73 | AGX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.8x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.01B | $4.53B | $478.2M | AGX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AGX REV | LGN REV | AGX GROSS % | LGN GROSS % | AGX FCF | LGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $944.6M | $2.55B | 20.5% | 21.0% | $410.8M | $218.9M |
| FY 2024 | $874.2M | $2.10B | 16.1% | 20.5% | $161.0M | $10.3M |
| FY 2023 | $573.3M | $1.62B | — | — | $91.1M | $33.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AGX // BETA 1.00
LGN // BETA —